ANDA 202946, held by Specgx LLC. Oxymorphone Hydrochloride.
As of Nov 16, 2026, ANDA 202946 (Oxymorphone Hydrochloride), held by Specgx LLC, was first approved by FDA on Jun 27, 2014, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 27, 2014 | Original application | Approved |
| Oxymorphone Hydrochloride5MG · tablet, extended release;oral | Oxymorphone Hydrochloride | Discontinued |
| Oxymorphone Hydrochloride7.5MG · tablet, extended release;oral | Oxymorphone Hydrochloride | Discontinued |
| Oxymorphone Hydrochloride10MG · tablet, extended release;oral | Oxymorphone Hydrochloride | Discontinued |
| Oxymorphone Hydrochloride15MG · tablet, extended release;oral | Oxymorphone Hydrochloride | Discontinued |
| Oxymorphone Hydrochloride20MG · tablet, extended release;oral | Oxymorphone Hydrochloride | Discontinued |
| Oxymorphone Hydrochloride30MG · tablet, extended release;oral | Oxymorphone Hydrochloride | Discontinued |
| Oxymorphone Hydrochloride40MG · tablet, extended release;oral | Oxymorphone Hydrochloride | Discontinued |
| Mar 4, 2021 | Supplement 11Labeling · Standard review | Approved | None posted |
| Oct 11, 2019 | Supplement 10Labeling · Standard review | Approved | None posted |
| Sep 20, 2018 | Supplement 9Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 8REMS | Approved | None posted |
| May 26, 2017 | Supplement 7REMS | Approved | None posted |
| Dec 16, 2016 | Supplement 4Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 6Labeling · Standard review | Approved | None posted |
| Sep 30, 2016 | Supplement 5REMS | Approved | None posted |
| Apr 20, 2016 | Supplement 3REMS | Approved | None posted |
| Jun 26, 2015 | Supplement 2REMS | Approved | None posted |
| Aug 19, 2014 | Supplement 1REMS | Approved | None posted |
| Jun 27, 2014 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters